T1	Participants 311 352	men with locally advanced prostate cancer
T2	Participants 449 530	NCIC Clinical Trials Group PR.3/Medical Research Council PR07/Intergroup T94-0110
T3	Participants 1051 1089	One thousand two hundred five patients
T4	Participants 1051 1134	One thousand two hundred five patients were randomly assigned between 1995 and 2005
